UroGen nets $141mm through followon offering

UroGen nets $141mm through follow-on offering

14:40 EST 25 Jan 2019 | Elsevier Business Intelligence

UroGen Pharma Ltd. (uro-oncology) netted $141mm through the public sale of 3.7mm common shares at $41. Funds will support wor...

Original Article: UroGen nets $141mm through follow-on offering

More From BioPortfolio on "UroGen nets $141mm through follow-on offering"